Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4476 (miR-4476) is a small, non-coding RNA molecule classified as a microRNA, involved in the post-transcriptional regulation of gene expression. It is upregulated in glioma and promotes tumor cell proliferation, migration, and invasion. Mechanistically, miR-4476 directly represses the tumor suppressor gene APC, leading to activation of the Wnt/β-catenin/c-Jun signaling pathway, which contributes to tumor growth and malignancy. Clinical studies have found that miR-4476 is a prognostic biomarker in glioma, with higher expression correlating with poor patient survival[1][2]. Its dysregulation has also been observed in pancreatic and biliary tract cancers, supporting a broader oncogenic role. There are currently no approved drugs targeting miR-4476 directly, and its modulation for therapy is still an area of research[2][4].
Post-transcriptional repression of mRNA, targeting of tumor suppressor gene APC
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4476 (miR-4476).